Wearables And AI Will Empower Premium Health Markets

Published
13 Apr 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
US$285.00
18.5% undervalued intrinsic discount
15 Aug
US$232.34
Loading
1Y
35.0%
7D
-0.02%

Author's Valuation

US$285.0

18.5% undervalued intrinsic discount

AnalystHighTarget Fair Value

Shared on07 May 25
Fair value Increased 2.41%

Shared on30 Apr 25

AnalystHighTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25

AnalystHighTarget has increased future PE multiple from 31.2x to 34.5x.

Shared on16 Apr 25
Fair value Decreased 9.76%

AnalystHighTarget made no meaningful changes to valuation assumptions.